Article metrics

Download PDFPDF

POS1027 EFFICACY AND SAFETY OF GUSELKUMAB, A MONOCLONAL ANTIBODY SPECIFIC TO THE p19-SUBUNIT OF INTERLEUKIN-23, THROUGH 2 YEARS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Free

 

Online download statistics by month:

Online download statistics by month: May 2021 to September 2021

AbstractFullPdf
May 20218015
Jun 20214020
Jul 20213050
Aug 20211033
Sep 20212027
Total180145